Zobrazeno 1 - 10 of 121 pro vyhledávání: '"Eric Berthelet"'
1
Akademický článek
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression
Autor: Marie-Hélène Denault, Jamie Feng, Shelley Kuang, Aria Shokoohi, Bonnie Leung, Mitchell Liu, Eric Berthelet, Janessa Laskin, Sophie Sun, Tina Zhang, Cheryl Ho, Barbara Melosky
Publikováno v: Current Oncology, Vol 30, Iss 8, Pp 7499-7507 (2023)
Adjuvant durvalumab after chemoradiotherapy (CRT) is the standard of care for unresectable stage III non-small cell lung cancer (NSCLC). A post hoc exploratory analysis of PACIFIC revealed no OS benefit in the PD-L1 < 1% subgroup. This retrospective
Externí odkaz: https://doaj.org/article/abc42c904bd04f11bcc54c5692ead44a
Zobrazit plný text záznamu
2
Akademický článek
Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report
Autor: Marie-Hélène Denault, MD, MSc, Shelley Kuang, MD, FRCPC, Aria Shokoohi, BSc, Bonnie Leung, MN-NP, Mitchell Liu, MDCM, FRCPC, Eric Berthelet, MD, FRCPC, Janessa Laskin, MD, FRCPC, Sophie Sun, MD, FRCPC, Tina Zhang, MD, FRCPC, Barbara Melosky, MD, FRCPC, Cheryl Ho, MD, FRCPC
Publikováno v: JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100316- (2022)
Introduction: Durvalumab 10 mg/kg every 2 weeks for 1 year after chemoradiation has improved overall survival (OS) in unresectable stage III NSCLC. Subsequently, a 20 mg/kg 4-weekly regimen was approved. The study goal was to compare the efficacy and
Externí odkaz: https://doaj.org/article/bde7a2a808be4a1aa4e9265d197f84cb
Zobrazit plný text záznamu
5
The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status
Autor: Ryan, Urban, Fatimah, Alfaraj, Robert, Olson, Eric, Berthelet, Eric, Tran, Jonn, Wu, Jeremy, Hamm, Sarah, Hamilton
Publikováno v: American Journal of Clinical Oncology. 45:122-128
A retrospective analysis was performed to evaluate the prognostic significance of treatment delays (TDs) for oropharynx carcinoma patients treated with definitive radiotherapy (RT), comparing p16+ versus p16- disease.Patients treated between 2012 and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42aca6585444170303b073cd49481a0a
https://doi.org/10.1097/coc.0000000000000891
Zobrazit plný text záznamu
6
Ninety‐day mortality after radiotherapy for head and neck cancer: Population‐based comparison between rural and urban patients
Autor: Jonn Wu, Siske Bos, Sarah Hamilton, Robert Olson, Roel Schlijper, Eric Tran, Eric Berthelet
Publikováno v: Head & Neck. 43:3306-3313
BACKGROUND This study assesses whether 90-day mortality differs between patients living in rural and urban areas, as lower access to supportive care services in rural areas could result in higher mortality. METHODS All patients with head and neck can
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06192e3cf4276b9eb365d9a2c9c16ff7
https://doi.org/10.1002/hed.26819
Zobrazit plný text záznamu
9
A Unique Case of Primary EBV-Positive, HPV-Negative Nasopharyngeal Carcinoma Located in the Tonsil
Autor: Timothy Kong, Eitan Prisman, Eric Berthelet, Tony Ng, Sally Nguyen
Publikováno v: Head Neck Pathol
Nasopharyngeal carcinomas (NPC) are non-keratinizing squamous cell carcinomas of the nasopharynx associated with Epstein-Barr virus (EBV). When occurring outside of the nasopharynx, they are referred to as lymphoepithelioma-like carcinomas (LELCs) an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6de058b4cd9d1207458239eef7d48a
https://doi.org/10.1007/s12105-020-01237-w
Zobrazit plný text záznamu
10
FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status
Autor: Don Wilson, Kimberly DeVries, Robert Olson, Ryan Urban, Sarah Hamilton, Jonn Wu, Eric Tran, Eric Berthelet, Tassia Godoy
Publikováno v: Radiotherapy and Oncology. 148:14-20
Purpose To evaluate the predictive value of FDG-PET/CT for detection of residual disease after radical radiotherapy for patients with squamous cell carcinoma (SCC) of the oropharynx, comparing p16 positive (+) versus p16 negative (−) disease. Metho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904241a4345cb9022f3aab9d98c0b1ae
https://doi.org/10.1016/j.radonc.2020.03.032
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje